Contacts to general practitioners and renewal of antihypertensive medication - a four-year follow-up in primary health care, Turku, Finland

dc.contributor.authorJohansson, Jouni K.
dc.contributor.authorKorhonen, Päivi
dc.contributor.organizationfi=lääketieteellinen tiedekunta|en=Faculty of Medicine|
dc.contributor.organizationfi=tyks, vsshp|en=tyks, varha|
dc.contributor.organizationfi=yleislääketiede|en=General Practice|
dc.contributor.organization-code1.2.246.10.2458963.20.13290506867
dc.contributor.organization-code1.2.246.10.2458963.20.21889691131
dc.converis.publication-id505550268
dc.converis.urlhttps://research.utu.fi/converis/portal/Publication/505550268
dc.date.accessioned2026-04-24T15:44:40Z
dc.description.abstract<h3>Background</h3><p>Persistence with medication is central to the effectiveness of antihypertensive therapy.</p><p>Electronic communication between patients and doctors may have potential to improve medication persistence among patients with hypertension. Our objective was to examine the use of antihypertensive medication in subjects with hypertension in primary health care in Finland in a longitudinal setting.</p><h3>Methods</h3><p>From the primary health care register of the city of Turku in Southwestern Finland, subjects with the diagnosis of hypertension were identified. Data of number and type of antihypertensive medication was gathered in a 4-year follow-up.</p><h3>Results</h3><p>Sixty-one percent of the subjects with hypertension had 1-4 antihypertensive medications in regular use. Ten percent did not use antihypertensive medication at all. Higher age, higher number of GP (general practitioner) visits, telephone contacts and electronic communication and presence of diabetes were associated with regular use of antihypertensive medication.</p><p>The most common antihypertensive medication group in regular use was ACE inhibitor/ARB-blocker (41%), followed by beta blockers (18%), diuretics (16%) and calcium channel blockers (15%).</p><h3>Conclusions</h3><p>Regular use of antihypertensive therapy was associated with the use of frequent GP contacts during the 4-year follow-up.</p>
dc.identifier.eissn2731-4553
dc.identifier.urihttps://www.utupub.fi/handle/11111/58526
dc.identifier.urlhttps://link.springer.com/article/10.1186/s12875-025-03104-5
dc.identifier.urnURN:NBN:fi-fe2026022315382
dc.language.isoen
dc.okm.affiliatedauthorJohansson, Jouni
dc.okm.affiliatedauthorKorhonen, Päivi
dc.okm.affiliatedauthorDataimport, tyks, vsshp
dc.okm.discipline316 Nursingen_GB
dc.okm.discipline316 Hoitotiedefi_FI
dc.okm.internationalcopublicationnot an international co-publication
dc.okm.internationalityInternational publication
dc.okm.typeA1 ScientificArticle
dc.publisherBioMed Central
dc.publisher.countryUnited Kingdomen_GB
dc.publisher.countryBritanniafi_FI
dc.publisher.country-codeGB
dc.relation.articlenumber32
dc.relation.doi10.1186/s12875-025-03104-5
dc.relation.ispartofjournalBMC Primary Care
dc.relation.volume27
dc.titleContacts to general practitioners and renewal of antihypertensive medication - a four-year follow-up in primary health care, Turku, Finland
dc.year.issued2026

Tiedostot

Näytetään 1 - 1 / 1
Ladataan...
Name:
s12875-025-03104-5.pdf
Size:
1.33 MB
Format:
Adobe Portable Document Format